Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q3 2022 Earnings Call Transcript November 12, 2022
Operator: Good afternoon, and welcome to the Y-mAbs Therapeutics, Inc. Earnings Conference Call for the Third Quarter of 2022. . Let me quickly remind you that the following discussion contains certain statements that are considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about our...
